Financials data is unavailable for this security.
View more
Year on year Waverley Pharma Inc 's revenues fell -66.95% from 1.25m to 412.09k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 664.08k to a larger loss of 2.22m.
Gross margin | -16.68% |
---|---|
Net profit margin | -1,555.37% |
Operating margin | -1,522.01% |
Return on assets | -153.02% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in CADView more
In 2023, cash reserves at Waverley Pharma Inc fell by 80.78k. Cash Flow from Financing totalled 940.33k or 228.19% of revenues. In addition the company used 1.02m for operations while cash from investing was breakeven.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0323 |
---|---|
Tangible book value per share | -0.0372 |
More ▼
Balance sheet in CADView more
Current ratio | 0.0995 |
---|---|
Quick ratio | 0.0995 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 8.80 |
More ▼